MEDICA16, an ATP-citrate lyase inhibitor, significantly reduces intracellular TG content in gastrocnemius muscle, and this reduction is accompanied by an increase in insulin sensitivity. MEDICA16 is a selective agonist for GPR40 as well as selective partial agonists for GPR120[1][2].
Molecular Weight:
342.51
Purity:
98
CAS Number:
[87272-20-6]
Formula:
C20H38O4
Target:
ATP Citrate Lyase,Free Fatty Acid Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
